Drug Trial Radar · NCT06168799
Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery
Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
271
Actual
Start
Dec 19, 2023
Primary completion
Oct 5, 2025
Study completion Dec 3, 2025
Sponsor
- Lead sponsor
- AM-PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- FGK Clinical Research GmbH
- First posted
- Dec 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this clinical trial is to evaluate the efficacy and safety of two intravenous administrations of ilofotase alfa in patients at risk for renal damage following open heart surgery.
Conditions
- Open Heart Surgery
Interventions
Ilofotase alfaDrug
After dilution of the concentrate, the investigational medicinal product will be administered by intravenous infusion for 1 hour at the same day before and after the surgery (Day 1)
PlaceboDrug
After dilution of the concentrate, the investigational medicinal product will be administered by intravenous infusion for 1 hour at the same day before and after the surgery (Day 1)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum Creatinine Level RatioTime frame: From Baseline (Day -1/1) to Day 5
Locations
13 sites in 5 countries. Site status is shown where the registry gives one.
Ziekenhuis Oost Limburg
Genk, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Algemeen Ziekenhuis Delta
Roeselare, Belgium
Universität Duisburg-Essen, Klinik für Thorax- und Kardiovaskuläre Chirurgie
Essen, Germany
Deutsches Herzzentrum Muenchen Des Freistaates Bayern Klinik An Der Technischen Universitaet Muenchen
Munich, Germany
Westfaelische Wilhelms-Universitaet Muenster
Münster, Germany
Universitätsklinikum für Anästhesiologie und Intensivmedizin, Universitätsklinikum Tübingen
Tübingen, Germany
Academisch Medisch Centrum Amsterdam
Amsterdam, Netherlands
Stichting Radboud University Medical Center
Nijmegen, Netherlands
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Rotterdam, Netherlands
Universitätsspital Bern Universitätsklinik für Herzchirurgie
Bern, Switzerland
Centre hospitalier universitaire vaudois (CHUV)
Lausanne, Switzerland
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.